Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
23 November 2022 | Story André Damons

The Department of Pharmacology at the University of the Free State (UFS), together with the Technology Innovation Agency (TIA), is hosting the first Indigenous Knowledge and Bio-Trade Indaba on the Bloemfontein Campus. The Department of Science and Innovation (DSI) and TIA are the sponsors of the event. 

Prof Motlalepula Matsabisa, Professor and Director of Pharmacology, will play host to the various stakeholders to network and share knowledge on current developments in indigenous knowledge research and product development, biodiversity, innovation, and commercialisation of the IK-based research products. The Indigenous Knowledge System (IKS) for Health unit in the Department of Pharmacology within the UFS Faculty of Health Sciences was last year awarded an annual Technology Innovation Agency Platform (TIA) grant of R17 million for the next five years.

The research and teaching programme in the School of Clinical Medicine has since been rebranded and is now known as the African Medicines Innovation and Technology Development Platform (AMITD), which will strive to respond to community health needs and address industry research needs and challenges.

The indaba will showcase progress made by TIA and other entities in enriching the development and commercialisation of IK-based innovations. It will take place from 24 to 25 November 2022 in the Equitas Senate Hall at the UFS. 

Prof Matsabisa is the chairperson of the World Health Organisation’s (WHO) Regional Expert Advisory Committee on Traditional Medicines for COVID-19. He is also a visiting professor at the Beijing University of Chinese Medicine (BUCM) in Beijing, China, and the Deputy President of the South African Society for Basic and Clinical Pharmacology.
 

News Archive

Stained glass artist’s hard work recognised
2016-07-13

Description: Bongani Njalo Tags: Bongani Njalo

Bongani Njalo, project co-ordinator for the
Program for Innovation in Artform Development,
was recognised as one of the 200 Young
South Africans by the Mail & Guardian category
for the year 2016.
Photo: Siobhan Canavan

“I’ve used each highlight of my career as a benchmark for greater accomplishments.”

These are the words of Bongani Njalo, who was selected as one of the Mail & Guardian 200 Young South Africans together with Adv Loyiso Makapela, Junior Lecturer at the University of the Free State (UFS) Law Faculty. Njalo was recognised in the Arts and Culture category for his outstanding contribution to the art scene.

Getting to know the artist

The fine art graduate has worked on different art projects in several cities, and is currently the project co-ordinator for the Program for Innovation in Artform Development (PIAD). PIAD is a programme developed by the UFS and the Vrystaat Arts Festival, which focuses on how technology, interdisciplinary and experimental arts can connect with and impact on communities.

Aspiring artist on the move

Soon, this young artist will be on the move again, as he has been accepted into the Internal Leadership Program in Visual Arts Management at Deusto Business School, taking place in Bilbao in Spain in November and in New York next March.

When asked about the nomination, Njalo simply said: “To be honest with you, I don’t feel any differently whatsoever. I now feel I have more work I’d like to do.”

A man of many talents

Not only was Njalo an intern at the Mandela Bay Development Agency where he compiled the book entitled Art & Artists of the Eastern Cape, but he also curated the Eastern Cape Artists Exhibition at the Grahamstown National Arts Festival in 2011.

In 2012, Njalo was invited to curate a group exhibition, Beehive, for the Cape Town International Month of Photography Festival, and in 2014 he won the David Koloane Mentorship Award.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept